Home/Investors/IP Group

IP Group

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

5

Top Stage

Phase 1

Investment Focus

Oncology Immunology Cystic Fibrosis Asthma COPD

Portfolio Companies

Company	Stage	Valuation	Focus
Crescendo Biologics	Phase 1	—	Oncology, Immunology
Enterprise Therapeutics	Phase 1	—	Cystic Fibrosis, Asthma

Frequent Co-Investors

Forbion1 shared Takeda1 shared Andera Partners1 shared Versant Ventures1 shared Quan Capital1 shared Novartis Venture Fund1 shared Sofinnova Partners1 shared BioNTech1 shared